Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / Fund iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker DRDR(GBX) LSE
ETF Ticker 2B78(EUR) F
ETF Ticker 2B78.DE(EUR) CXE
ETF Ticker DRDR.LS(GBX) CXE
ETF Ticker HEAL.AS(EUR) CXE
ETF Ticker HEAL.LS(USD) CXE
ETF Ticker HEALz(USD) CXE
ETF Ticker HEAL(EUR) ETF Plus
ETF Ticker DRDR.L(GBP) LSE

Holdings detail for RGEN

Stock Name	Repligen Corporation
Ticker	RGEN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US7599161095
LEI	54930006QJ0T5AUO1E71

Show aggregate RGEN holdings

News associated with RGEN

Repligen Corporation (NASDAQ:RGEN) Receives Average Recommendation of “Moderate Buy” from Analysts: Repligen Corporation (NASDAQ:RGEN – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms that are currently covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price […] - 2025-09-19 03:14:49
Repligen Corporation (NASDAQ:RGEN) Receives $169.45 Average Target Price from Analysts: Repligen Corporation (NASDAQ:RGEN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eleven ratings firms that are presently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price target […] - 2025-08-28 03:14:53
Rep. Lisa C. McClain Sells Off Shares of Repligen Corporation (NASDAQ:RGEN): Representative Lisa C. McClain (R-Michigan) recently sold shares of Repligen Corporation (NASDAQ:RGEN). In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Repligen stock on June 17th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account. Representative Lisa C. McClain also recently made […] - 2025-08-21 03:08:43
Swiss National Bank Sells 1,500 Shares of Repligen Corporation (NASDAQ:RGEN): Swiss National Bank decreased its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 1.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,200 shares of the biotechnology company’s stock after selling 1,500 shares during the quarter. Swiss […] - 2025-08-15 05:44:53
Repligen Corporation (NASDAQ:RGEN) Shares Acquired by PNC Financial Services Group Inc.: PNC Financial Services Group Inc. lifted its position in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 4.4% in the first quarter, Holdings Channel reports. The firm owned 3,632 shares of the biotechnology company’s stock after purchasing an additional 152 shares during the period. PNC Financial Services Group Inc.’s holdings in Repligen were worth […] - 2025-08-14 05:32:58
Wealthquest Corp Invests $264,000 in Repligen Corporation (NASDAQ:RGEN): Wealthquest Corp acquired a new position in Repligen Corporation (NASDAQ:RGEN – Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 2,077 shares of the biotechnology company’s stock, valued at approximately $264,000. Other hedge funds have also recently bought and sold shares of the […] - 2025-08-01 04:44:56
Thornburg Investment Management Inc. Has $4.29 Million Position in Repligen Corporation (NASDAQ:RGEN): Thornburg Investment Management Inc. trimmed its stake in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 4.7% in the first quarter, Holdings Channel.com reports. The firm owned 33,720 shares of the biotechnology company’s stock after selling 1,646 shares during the quarter. Thornburg Investment Management Inc.’s holdings in Repligen were worth $4,291,000 at the end […] - 2025-07-30 04:44:45
Repligen Corporation (NASDAQ:RGEN) Shares Bought by Signaturefd LLC: Signaturefd LLC raised its position in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 65.3% during the 1st quarter, Holdings Channel reports. The firm owned 324 shares of the biotechnology company’s stock after buying an additional 128 shares during the quarter. Signaturefd LLC’s holdings in Repligen were worth $41,000 as of its most recent […] - 2025-07-24 05:00:47
Ballentine Partners LLC Has $224,000 Stock Holdings in Repligen Corporation (NASDAQ:RGEN): Ballentine Partners LLC lessened its stake in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 6.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,759 shares of the biotechnology company’s stock after selling 120 shares during the period. […] - 2025-07-17 06:05:50
Allworth Financial LP Sells 733 Shares of Repligen Corporation (NASDAQ:RGEN): Allworth Financial LP reduced its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 47.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 809 shares of the biotechnology company’s stock after selling 733 shares during the quarter. Allworth Financial LP’s […] - 2025-07-17 05:25:12
Repligen Corporation (NASDAQ:RGEN) Shares Bought by State of Michigan Retirement System: State of Michigan Retirement System grew its holdings in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 0.8% in the 1st quarter, Holdings Channel reports. The fund owned 12,453 shares of the biotechnology company’s stock after acquiring an additional 100 shares during the period. State of Michigan Retirement System’s holdings in Repligen were worth […] - 2025-07-15 06:28:23
DekaBank Deutsche Girozentrale Decreases Holdings in Repligen Corporation (NASDAQ:RGEN): DekaBank Deutsche Girozentrale trimmed its holdings in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 1.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,750 shares of the biotechnology company’s stock after selling 80 shares during the period. DekaBank Deutsche […] - 2025-07-14 05:34:50
Repligen Corporation (NASDAQ:RGEN) Shares Acquired by Teacher Retirement System of Texas: Teacher Retirement System of Texas grew its holdings in Repligen Corporation (NASDAQ:RGEN – Free Report) by 61.7% during the 1st quarter, HoldingsChannel.com reports. The firm owned 15,811 shares of the biotechnology company’s stock after buying an additional 6,036 shares during the period. Teacher Retirement System of Texas’ holdings in Repligen were worth $2,012,000 at the […] - 2025-07-11 05:50:59
Repligen (NASDAQ:RGEN) Price Target Cut to $130.00 by Analysts at Evercore ISI: Repligen (NASDAQ:RGEN – Free Report) had its target price cut by Evercore ISI from $140.00 to $130.00 in a report issued on Tuesday morning,Benzinga reports. They currently have an in-line rating on the biotechnology company’s stock. A number of other brokerages have also recently issued reports on RGEN. Wall Street Zen cut shares of Repligen […] - 2025-07-11 03:08:46
Principal Financial Group Inc. Boosts Holdings in Repligen Corporation (NASDAQ:RGEN): Principal Financial Group Inc. grew its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 55.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 186,715 shares of the biotechnology company’s stock after purchasing an additional 66,808 shares during the period. Principal Financial Group Inc.’s holdings in Repligen were worth $23,758,000 at the end […] - 2025-07-09 05:51:35
New York State Teachers Retirement System Has $6.49 Million Stake in Repligen Corporation (NASDAQ:RGEN): New York State Teachers Retirement System reduced its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 5.4% during the first quarter, HoldingsChannel reports. The firm owned 51,032 shares of the biotechnology company’s stock after selling 2,900 shares during the period. New York State Teachers Retirement System’s holdings in Repligen were worth $6,493,000 at the […] - 2025-07-06 06:14:54
Mirae Asset Global Investments Co. Ltd. Purchases 11,193 Shares of Repligen Corporation (NASDAQ:RGEN): Mirae Asset Global Investments Co. Ltd. boosted its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 60.1% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 29,822 shares of the biotechnology company’s stock after purchasing an additional 11,193 shares during the period. Mirae Asset Global Investments […] - 2025-07-02 06:04:50
Retirement Systems of Alabama Acquires 86 Shares of Repligen Corporation (NASDAQ:RGEN): Retirement Systems of Alabama boosted its holdings in Repligen Corporation (NASDAQ:RGEN – Free Report) by 0.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 63,418 shares of the biotechnology company’s stock after acquiring an additional 86 shares during the period. Retirement […] - 2025-06-24 05:32:52
Analysts Anticipate IYH To Hit $66: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-23 08:47:36
Analysts Anticipate IYH To Hit $66: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-23 08:47:26
Parallel Advisors LLC Reduces Holdings in Repligen Co. (NASDAQ:RGEN): Parallel Advisors LLC reduced its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 30.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 285 shares of the biotechnology company’s stock after selling 123 shares during the quarter. Parallel Advisors LLC’s holdings in Repligen were worth $36,000 at the end of the most recent quarter. […] - 2025-06-10 04:46:53
Squarepoint Ops LLC Sells 81,814 Shares of Repligen Co. (NASDAQ:RGEN): Squarepoint Ops LLC reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 85.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,291 shares of the biotechnology company’s stock after selling 81,814 shares during the quarter. Squarepoint Ops LLC’s holdings in Repligen were worth $2,057,000 as of its most […] - 2025-05-29 05:52:48
ProShare Advisors LLC Has $351,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN): ProShare Advisors LLC increased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 7.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,438 shares of the biotechnology company’s stock after acquiring an additional 167 shares during the period. ProShare Advisors LLC’s […] - 2025-05-29 05:08:49
Tidal Investments LLC Decreases Stock Holdings in Repligen Co. (NASDAQ:RGEN): Tidal Investments LLC lowered its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 60.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,437 shares of the biotechnology company’s stock after selling 6,712 shares during the period. Tidal […] - 2025-05-28 05:52:53
The Math Shows MDY Can Go To $634: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-22 07:58:15
Repligen Co. (NASDAQ:RGEN) Shares Sold by Bank of America Corp DE: Bank of America Corp DE decreased its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 36.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 277,947 shares of the biotechnology company’s stock after selling 158,404 shares during the period. Bank of America […] - 2025-05-16 06:38:55
Financial Survey: Repligen (NASDAQ:RGEN) & Maze Therapeutics (NASDAQ:MAZE): Repligen (NASDAQ:RGEN – Get Free Report) and Maze Therapeutics (NASDAQ:MAZE – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings. Analyst Recommendations This is a summary of recent recommendations […] - 2025-05-16 02:09:10
Repligen (NASDAQ:RGEN) Given Buy Rating at HC Wainwright: Repligen (NASDAQ:RGEN – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $180.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price would suggest a potential upside of 38.04% from the stock’s previous close. […] - 2025-05-07 02:58:48
Repligen (NASDAQ:RGEN) Given New $190.00 Price Target at JPMorgan Chase & Co.: Repligen (NASDAQ:RGEN – Free Report) had its target price trimmed by JPMorgan Chase & Co. from $200.00 to $190.00 in a research note published on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the biotechnology company’s stock. RGEN has been the subject of several other reports. Wolfe Research raised shares of Repligen […] - 2025-04-30 05:32:52
Repligen (NASDAQ:RGEN) Upgraded by Wolfe Research to Outperform Rating: Wolfe Research upgraded shares of Repligen (NASDAQ:RGEN – Free Report) from a peer perform rating to an outperform rating in a report published on Tuesday, Marketbeat.com reports. They currently have $160.00 price objective on the biotechnology company’s stock. A number of other research firms have also weighed in on RGEN. Royal Bank of Canada upped […] - 2025-04-30 05:32:47

iShares Healthcare Innovation UCITS ETF USD (Acc) RGEN holdings

Date	Number of RGEN Shares Held	Base Market Value of RGEN Shares	Local Market Value of RGEN Shares	Change in RGEN Base Value	Current Price per RGEN Share Held	Previous Price per RGEN Share Held
2025-11-11 (Tuesday)	63,908	USD 9,806,044	USD 9,806,044	USD 497,205	USD 153.44	USD 145.66
2025-11-10 (Monday)	63,908	USD 9,308,839	USD 9,308,839	USD 181,498	USD 145.66	USD 142.82
2025-11-07 (Friday)	63,908	USD 9,127,341	USD 9,127,341	USD -138,041	USD 142.82	USD 144.98
2025-11-06 (Thursday)	63,908	USD 9,265,382	USD 9,265,382	USD -54,961	USD 144.98	USD 145.84
2025-11-05 (Wednesday)	63,908	USD 9,320,343	USD 9,320,343	USD -69,659	USD 145.84	USD 146.93
2025-11-04 (Tuesday)	63,908	USD 9,390,002	USD 9,390,002	USD -207,062	USD 146.93	USD 150.17
2025-11-03 (Monday)	63,908	USD 9,597,064	USD 9,597,064	USD 70,938	USD 150.17	USD 149.06
2025-10-31 (Friday)	63,908	USD 9,526,126	USD 9,526,126	USD 286,946	USD 149.06	USD 144.57
2025-10-30 (Thursday)	63,908	USD 9,239,180	USD 9,239,180	USD -249,880	USD 144.57	USD 148.48
2025-10-29 (Wednesday)	63,908	USD 9,489,060	USD 9,489,060	USD -197,476	USD 148.48	USD 151.57
2025-10-28 (Tuesday)	63,908	USD 9,686,536	USD 9,686,536	USD -609,043	USD 151.57	USD 161.1
2025-10-27 (Monday)	63,908	USD 10,295,579	USD 10,295,579	USD -334,239	USD 161.1	USD 166.33

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RGEN by Blackrock for IE00BYZK4776

Show aggregate share trades of RGEN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-10-24 SELL -542 166.330 169.870 169.516 USD -91,878 138.02 Loss of -17,073 on sale
2025-09-11 BUY 271 119.510 122.710 122.390 USD 33,168 137.67
2025-07-08 SELL -271 128.560 129.380 129.298 USD -35,040 139.16 Profit of 2,673 on sale
2025-06-24 SELL -271 123.350 125.030 124.862 USD -33,838 140.07 Profit of 4,122 on sale
2025-06-23 SELL -271 120.110 120.280 120.263 USD -32,591 140.22 Profit of 5,407 on sale
2025-06-11 SELL -271 132.000 135.300 134.970 USD -36,577 141.22 Profit of 1,692 on sale
2025-05-30 SELL -271 118.070 121.880 121.499 USD -32,926 142.22 Profit of 5,615 on sale
2025-05-21 BUY 271 120.210 126.190 125.592 USD 34,035 143.55
2025-05-14 SELL -1,626 128.040 134.250 133.629 USD -217,281 144.17 Profit of 17,138 on sale
2025-04-30 SELL -271 137.990 139.540 139.385 USD -37,773 145.26 Profit of 1,593 on sale
2025-04-28 SELL -271 143.630 148.380 147.905 USD -40,082 145.34 Loss of -696 on sale
2025-04-25 SELL -271 144.750 145.960 145.839 USD -39,522 145.34 Loss of -134 on sale
2025-04-11 SELL -1,626 122.860 123.240 123.202 USD -200,326 146.41 Profit of 37,730 on sale
2025-04-08 SELL -813 108.890 122.690 121.310 USD -98,625 147.46 Profit of 21,256 on sale
2025-04-07 BUY 772 116.110 121.840 121.267 USD 93,618 147.82
2025-03-31 SELL -532 127.240 131.160 130.768 USD -69,569 148.95 Profit of 9,673 on sale
2025-03-21 SELL -532 140.020 140.390 140.353 USD -74,668 149.70 Profit of 4,970 on sale
2025-03-12 SELL -266 145.370 149.660 149.231 USD -39,695 150.10 Profit of 232 on sale
2025-02-28 SELL -266 159.260 160.050 159.971 USD -42,552 149.67 Loss of -2,740 on sale
2025-02-25 BUY 266 161.470 165.470 165.070 USD 43,909 149.12
2025-02-20 SELL -266 162.670 169.000 168.367 USD -44,786 148.41 Loss of -5,307 on sale
2025-02-19 BUY 532 150.730 151.320 151.261 USD 80,471 148.37
2025-02-18 BUY 266 145.180 149.040 148.654 USD 39,542 148.43
2024-12-30 BUY 649 143.810 145.030 144.908 USD 94,045 142.79
2024-12-06 SELL -262 149.200 150.560 150.424 USD -39,411 141.87 Loss of -2,241 on sale
2024-12-04 SELL -262 149.090 150.780 150.611 USD -39,460 141.60 Loss of -2,361 on sale
2024-12-03 SELL -524 148.500 149.810 149.679 USD -78,432 141.34 Loss of -4,367 on sale
2024-11-22 BUY 599 142.580 145.210 144.947 USD 86,823 139.00
2024-11-21 SELL -260 141.760 142.110 142.075 USD -36,940 138.85 Loss of -838 on sale
2024-11-20 SELL -261 138.900 139.200 139.170 USD -36,323 138.85 Loss of -84 on sale
2024-11-19 SELL -261 128.490 128.980 128.931 USD -33,651 139.46 Profit of 2,748 on sale
2024-11-18 SELL -1,036 123.410 126.250 125.966 USD -130,501 140.46 Profit of 15,017 on sale
2024-11-12 SELL -259 148.590 154.480 153.891 USD -39,858 139.92 Loss of -3,619 on sale
2024-11-07 SELL -259 143.880 146.350 146.103 USD -37,841 139.55 Loss of -1,696 on sale
2024-11-05 SELL -518 145.950 146.030 146.022 USD -75,639 138.39 Loss of -3,951 on sale
2024-10-28 SELL -259 137.210 138.240 138.137 USD -35,777 140.29 Profit of 558 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-10-24	SELL	-542	166.330	169.870	169.516	USD -91,878	138.02 Loss of -17,073 on sale
2025-09-11	BUY	271	119.510	122.710	122.390	USD 33,168	137.67
2025-07-08	SELL	-271	128.560	129.380	129.298	USD -35,040	139.16 Profit of 2,673 on sale
2025-06-24	SELL	-271	123.350	125.030	124.862	USD -33,838	140.07 Profit of 4,122 on sale
2025-06-23	SELL	-271	120.110	120.280	120.263	USD -32,591	140.22 Profit of 5,407 on sale
2025-06-11	SELL	-271	132.000	135.300	134.970	USD -36,577	141.22 Profit of 1,692 on sale
2025-05-30	SELL	-271	118.070	121.880	121.499	USD -32,926	142.22 Profit of 5,615 on sale
2025-05-21	BUY	271	120.210	126.190	125.592	USD 34,035	143.55
2025-05-14	SELL	-1,626	128.040	134.250	133.629	USD -217,281	144.17 Profit of 17,138 on sale
2025-04-30	SELL	-271	137.990	139.540	139.385	USD -37,773	145.26 Profit of 1,593 on sale
2025-04-28	SELL	-271	143.630	148.380	147.905	USD -40,082	145.34 Loss of -696 on sale
2025-04-25	SELL	-271	144.750	145.960	145.839	USD -39,522	145.34 Loss of -134 on sale
2025-04-11	SELL	-1,626	122.860	123.240	123.202	USD -200,326	146.41 Profit of 37,730 on sale
2025-04-08	SELL	-813	108.890	122.690	121.310	USD -98,625	147.46 Profit of 21,256 on sale
2025-04-07	BUY	772	116.110	121.840	121.267	USD 93,618	147.82
2025-03-31	SELL	-532	127.240	131.160	130.768	USD -69,569	148.95 Profit of 9,673 on sale
2025-03-21	SELL	-532	140.020	140.390	140.353	USD -74,668	149.70 Profit of 4,970 on sale
2025-03-12	SELL	-266	145.370	149.660	149.231	USD -39,695	150.10 Profit of 232 on sale
2025-02-28	SELL	-266	159.260	160.050	159.971	USD -42,552	149.67 Loss of -2,740 on sale
2025-02-25	BUY	266	161.470	165.470	165.070	USD 43,909	149.12
2025-02-20	SELL	-266	162.670	169.000	168.367	USD -44,786	148.41 Loss of -5,307 on sale
2025-02-19	BUY	532	150.730	151.320	151.261	USD 80,471	148.37
2025-02-18	BUY	266	145.180	149.040	148.654	USD 39,542	148.43
2024-12-30	BUY	649	143.810	145.030	144.908	USD 94,045	142.79
2024-12-06	SELL	-262	149.200	150.560	150.424	USD -39,411	141.87 Loss of -2,241 on sale
2024-12-04	SELL	-262	149.090	150.780	150.611	USD -39,460	141.60 Loss of -2,361 on sale
2024-12-03	SELL	-524	148.500	149.810	149.679	USD -78,432	141.34 Loss of -4,367 on sale
2024-11-22	BUY	599	142.580	145.210	144.947	USD 86,823	139.00
2024-11-21	SELL	-260	141.760	142.110	142.075	USD -36,940	138.85 Loss of -838 on sale
2024-11-20	SELL	-261	138.900	139.200	139.170	USD -36,323	138.85 Loss of -84 on sale
2024-11-19	SELL	-261	128.490	128.980	128.931	USD -33,651	139.46 Profit of 2,748 on sale
2024-11-18	SELL	-1,036	123.410	126.250	125.966	USD -130,501	140.46 Profit of 15,017 on sale
2024-11-12	SELL	-259	148.590	154.480	153.891	USD -39,858	139.92 Loss of -3,619 on sale
2024-11-07	SELL	-259	143.880	146.350	146.103	USD -37,841	139.55 Loss of -1,696 on sale
2024-11-05	SELL	-518	145.950	146.030	146.022	USD -75,639	138.39 Loss of -3,951 on sale
2024-10-28	SELL	-259	137.210	138.240	138.137	USD -35,777	140.29 Profit of 558 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RGEN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	184,830	0	275,187	67.2%
2025-09-18	149,326	150	235,411	63.4%
2025-09-17	244,210	0	450,062	54.3%
2025-09-16	244,804	0	507,883	48.2%
2025-09-15	82,951	200	234,576	35.4%
2025-09-12	106,214	0	244,494	43.4%
2025-09-11	89,328	13	192,442	46.4%
2025-09-10	178,691	5	413,003	43.3%
2025-09-09	70,869	300	226,629	31.3%
2025-09-08	120,724	301	294,133	41.0%
2025-09-05	226,842	79	378,403	59.9%
2025-09-04	146,776	0	331,182	44.3%
2025-09-03	99,828	71	193,764	51.5%
2025-09-02	84,433	0	164,310	51.4%
2025-08-29	91,080	373	217,770	41.8%
2025-08-28	141,690	0	402,898	35.2%
2025-08-27	40,535	7	145,819	27.8%
2025-08-26	74,674	814	199,538	37.4%
2025-08-25	60,557	88	144,206	42.0%
2025-08-22	123,027	24	289,126	42.6%
2025-08-21	88,536	18	155,768	56.8%
2025-08-20	92,109	2	192,272	47.9%
2025-08-19	126,382	15	253,041	49.9%
2025-08-18	89,378	0	179,190	49.9%
2025-08-15	128,454	5	231,976	55.4%
2025-08-14	174,548	3	296,578	58.9%
2025-08-13	115,929	481	251,935	46.0%
2025-08-12	156,457	20	400,258	39.1%
2025-08-11	94,455	2,643	220,585	42.8%
2025-08-08	81,383	0	276,037	29.5%
2025-08-07	73,505	0	260,659	28.2%
2025-08-06	119,534	0	512,189	23.3%
2025-08-05	78,097	169	261,757	29.8%
2025-08-04	76,311	741	262,101	29.1%
2025-08-01	156,167	0	408,798	38.2%
2025-07-31	171,937	5	403,966	42.6%
2025-07-30	208,531	0	613,297	34.0%
2025-07-29	329,894	4	1,013,564	32.5%
2025-07-28	132,633	3,387	367,564	36.1%
2025-07-25	113,259	0	346,382	32.7%
2025-07-24	187,601	0	365,361	51.3%
2025-07-23	177,620	0	666,402	26.7%
2025-07-22	269,189	28,300	659,381	40.8%
2025-07-21	144,183	270	582,432	24.8%
2025-07-18	155,435	769	451,139	34.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Healthcare Innovation UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	DRDR(GBX) LSE
ETF Ticker	2B78(EUR) F
ETF Ticker	2B78.DE(EUR) CXE
ETF Ticker	DRDR.LS(GBX) CXE
ETF Ticker	HEAL.AS(EUR) CXE
ETF Ticker	HEAL.LS(USD) CXE
ETF Ticker	HEALz(USD) CXE
ETF Ticker	HEAL(EUR) ETF Plus
ETF Ticker	DRDR.L(GBP) LSE